This Page is intended to document Testing Issues , Trials , Vaccines and Treatments
There are two types of tests carried out for COVID-19, one is to confirm if you currently have the virus (PCR) and one is to ask if you have made antibodies against the virus (serology).
Swab Tests RT-PCR can indicate that a patient currently has the Virus
Antibody Tests show how many people have had the disease, including those whose symptoms were minor or who were asymptomatic.
Wiki COVID Testing
Clinical Guidance given to Clinicians by HM Government - COVID-19: investigation and initial clinical management of possible cases can be found on the link should a test referal be arrived at
The current Laboratory Availability to Clinicians for Patient Testing is as follows at regional laboratories
COVID-19: how hospital-based healthcare workers can arrange laboratory testing for patients
Wiki COVID Testing
Clinical Guidance given to Clinicians by HM Government - COVID-19: investigation and initial clinical management of possible cases can be found on the link should a test referal be arrived at
The current Laboratory Availability to Clinicians for Patient Testing is as follows at regional laboratories
COVID-19: how hospital-based healthcare workers can arrange laboratory testing for patients
Asymptomatic Transmission
Source Study: Many asymptomatic COVID-19 cases undetected
Theraputics
" There are curently no effective clinical therapeutics for COVID in the World at the moment " Matt Hancock PM briefing
Remdesevir Trials
Current Trials for this drug Tx are being reported as non effective
There is limitted evidence that it shortens recovery time for seriously hospitilised patients but it does not prevent the disease
Lancet 29th April 2020 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
There is limitted evidence that it shortens recovery time for seriously hospitilised patients but it does not prevent the disease
Lancet 29th April 2020 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
The Lancet: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed
Biopharm Leaked data on Gilead's remdesivir suggest drug didn't help patients with COVID-19
CBS Gilead Sciences stock rises on hopes for COVID-19 treatment
SNG001 20/ 07 2020 Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Vaccine
Commonly asked is How Long will it Take to arrive at a COVID-19 Vacine the simple answer is some considerable time underpinning the Governments limitted option - to isolate and maintain distance to stop infection and spread
Reviews
COVID-19 Vaccine and Antiviral Drug Development 8th April 2020 Part 2
No comments:
Post a Comment